These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36871101)

  • 1. The effects of Covid-19 mRNA vaccine on adolescence gynecological well-being.
    Mohr-Sasson A; Haas J; Sivan M; Zehori Y; Hemi R; Orvieto R; Afek A; Rabinovici J
    Arch Gynecol Obstet; 2023 May; 307(5):1625-1631. PubMed ID: 36871101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of Covid-19 mRNA vaccine on serum anti-Müllerian hormone levels.
    Mohr-Sasson A; Haas J; Abuhasira S; Sivan M; Doitch Amdurski H; Dadon T; Blumenfeld S; Derazne E; Hemi R; Orvieto R; Afek A; Rabinovici J
    Hum Reprod; 2022 Mar; 37(3):534-541. PubMed ID: 34935913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?
    Yildiz E; Timur B; Guney G; Timur H
    Medicine (Baltimore); 2023 May; 102(20):e33824. PubMed ID: 37335728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of SARS-CoV-2 mRNA vaccination on AMH concentrations in infertile women.
    Horowitz E; Mizrachi Y; Ganer Herman H; Oz Marcuschamer E; Shalev A; Farhi J; Barber E; Orna SH; Raziel A; Weissman A
    Reprod Biomed Online; 2022 Oct; 45(4):779-784. PubMed ID: 35985956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of COVID-19 vaccinations on menstrual cycle and serum anti-Mullerian hormone levels in reproductive age women.
    Hasdemir PS; Senol Akar S; Goker A; Kosova F; Ucar D; Ozalp Ates FS; Akcali S
    Hum Fertil (Camb); 2023 Feb; 26(1):153-161. PubMed ID: 36919413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of inactivated COVID-19 vaccination on female ovarian reserve: a propensity score-matched retrospective cohort study.
    Huang J; Guan T; Tian L; Xia L; Xu D; Wu X; Huang L; Chen M; Fang Z; Xiong C; Nie L; Wang S; Li Z; Zhao Y; Wu Q
    Front Immunol; 2023; 14():1198051. PubMed ID: 37638010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mRNA COVID-19 vaccine on ovarian reserve of women of reproductive age.
    Kumbasar S; Salman S; Çakmak GN; Ketenci Gencer F; Sicakyüz LS; Kumbasar AN
    Ginekol Pol; 2023 Oct; ():. PubMed ID: 37861223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study.
    Vinh DC; Gouin JP; Cruz-Santiago D; Canac-Marquis M; Bernier S; Bobeuf F; Sengupta A; Brassard JP; Guerra A; Dziarmaga R; Perez A; Sun Y; Li Y; Roussel L; Langelier MJ; Ke D; Arnold C; Whelan M; Pelchat M; Langlois MA; Zhang X; Mazer BD;
    Lancet Healthy Longev; 2022 Mar; 3(3):e166-e175. PubMed ID: 35224524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosting Dose of Pfizer-BioNtech mRNA Vaccine Against SARS-CoV-2 Does Not Affect Reproductive Outcomes in In-Vitro Fertilization Patients: A Cohort Study.
    Adler Lazarovits C; Smadja A; Kabessa M; Allouche Kam H; Nevo L; Godin M; Bentov Y; Beharier O; Esh Broder E; Holzer H; Hershko Klement A
    J Womens Health (Larchmt); 2023 Jan; 32(1):24-28. PubMed ID: 36413046
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of COVID-19 vaccine on ovarian reserve.
    Soysal Ç; Yılmaz E
    Saudi Med J; 2022 May; 43(5):486-490. PubMed ID: 35537728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inactivated SARS-CoV-2 vaccination on male fertility: A retrospective cohort study.
    Dong Y; Li X; Li Z; Zhu Y; Wei Z; He J; Cheng H; Yang A; Chen F
    J Med Virol; 2023 Jan; 95(1):e28329. PubMed ID: 36415120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
    Yang S; Li Y; Dai L; Wang J; He P; Li C; Fang X; Wang C; Zhao X; Huang E; Wu C; Zhong Z; Wang F; Duan X; Tian S; Wu L; Liu Y; Luo Y; Chen Z; Li F; Li J; Yu X; Ren H; Liu L; Meng S; Yan J; Hu Z; Gao L; Gao GF
    Lancet Infect Dis; 2021 Aug; 21(8):1107-1119. PubMed ID: 33773111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
    Beckley M; Olson AK; Portman MA
    JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative Analyses of IgA Antibody Response of Non-COVID-19 Infected People Over 60 Years Old Following CoronaVac and Pfizer-BioNTech COVID-19 Vaccination].
    Yürüker Ö; Yetkin O; Güvenir M
    Mikrobiyol Bul; 2023 Apr; 57(2):330-333. PubMed ID: 37067217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal study of AMH variations in 122 Adolescents and Young Adults (AYA) and non-AYA lymphoma patients to evaluate the chemo-induced ovarian toxicity to further personalise fertility preservation counselling.
    Decanter C; Delepine J; Behal H; Manier S; Bruno B; Barbatti M; Robin C; Labreuche J; Morschhauser F; Pigny P
    Hum Reprod; 2021 Sep; 36(10):2743-2752. PubMed ID: 34417822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Zhang Y; Zeng G; Pan H; Li C; Hu Y; Chu K; Han W; Chen Z; Tang R; Yin W; Chen X; Hu Y; Liu X; Jiang C; Li J; Yang M; Song Y; Wang X; Gao Q; Zhu F
    Lancet Infect Dis; 2021 Feb; 21(2):181-192. PubMed ID: 33217362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.